ZA200106787B - A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance. - Google Patents
A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance. Download PDFInfo
- Publication number
- ZA200106787B ZA200106787B ZA200106787A ZA200106787A ZA200106787B ZA 200106787 B ZA200106787 B ZA 200106787B ZA 200106787 A ZA200106787 A ZA 200106787A ZA 200106787 A ZA200106787 A ZA 200106787A ZA 200106787 B ZA200106787 B ZA 200106787B
- Authority
- ZA
- South Africa
- Prior art keywords
- tolerogenic
- protein
- peptides
- milk
- composition
- Prior art date
Links
- 230000003614 tolerogenic effect Effects 0.000 title claims description 91
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 84
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 66
- 239000000203 mixture Substances 0.000 title claims description 40
- 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 title claims description 22
- 230000000774 hypoallergenic effect Effects 0.000 title claims description 12
- 230000001939 inductive effect Effects 0.000 title description 7
- 235000018102 proteins Nutrition 0.000 claims description 46
- 102000004169 proteins and genes Human genes 0.000 claims description 46
- 108090000623 proteins and genes Proteins 0.000 claims description 46
- 239000011347 resin Substances 0.000 claims description 23
- 229920005989 resin Polymers 0.000 claims description 23
- 230000007062 hydrolysis Effects 0.000 claims description 20
- 238000006460 hydrolysis reaction Methods 0.000 claims description 20
- 102000014171 Milk Proteins Human genes 0.000 claims description 17
- 108010011756 Milk Proteins Proteins 0.000 claims description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 230000002009 allergenic effect Effects 0.000 claims description 16
- 239000003531 protein hydrolysate Substances 0.000 claims description 15
- 238000004587 chromatography analysis Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 206010016946 Food allergy Diseases 0.000 claims description 11
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 11
- 230000006698 induction Effects 0.000 claims description 11
- 235000021239 milk protein Nutrition 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 235000013336 milk Nutrition 0.000 claims description 7
- 239000008267 milk Substances 0.000 claims description 7
- 210000004080 milk Anatomy 0.000 claims description 7
- 208000009793 Milk Hypersensitivity Diseases 0.000 claims description 6
- 201000010859 Milk allergy Diseases 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 5
- 235000021240 caseins Nutrition 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 5
- 239000011707 mineral Substances 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 108010071390 Serum Albumin Proteins 0.000 claims description 2
- 102000007562 Serum Albumin Human genes 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- 239000000243 solution Substances 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 108010046377 Whey Proteins Proteins 0.000 description 15
- 235000020247 cow milk Nutrition 0.000 description 14
- 239000000413 hydrolysate Substances 0.000 description 12
- 235000021119 whey protein Nutrition 0.000 description 12
- 102000007544 Whey Proteins Human genes 0.000 description 11
- 230000004044 response Effects 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 8
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 230000000717 retained effect Effects 0.000 description 7
- 230000005951 type IV hypersensitivity Effects 0.000 description 7
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 7
- 239000004365 Protease Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 235000013350 formula milk Nutrition 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 239000013566 allergen Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 210000004988 splenocyte Anatomy 0.000 description 5
- 102000011632 Caseins Human genes 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- 239000005913 Maltodextrin Substances 0.000 description 4
- 229920002774 Maltodextrin Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 229940035034 maltodextrin Drugs 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000012466 permeate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 229960001322 trypsin Drugs 0.000 description 4
- 241000228212 Aspergillus Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 208000004262 Food Hypersensitivity Diseases 0.000 description 3
- 102000008192 Lactoglobulins Human genes 0.000 description 3
- 108010060630 Lactoglobulins Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000005862 Whey Substances 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000020932 food allergy Nutrition 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 230000009696 proliferative response Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 239000005905 Hydrolysed protein Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229940021722 caseins Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000001516 cell proliferation assay Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- -1 lactose 39 % Chemical class 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000004237 preparative chromatography Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000003393 splenic effect Effects 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 230000024664 tolerance induction Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 101800000112 Acidic peptide Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 108090000746 Chymosin Proteins 0.000 description 1
- 241000221756 Cryphonectria parasitica Species 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000213844 Lagoa Species 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000235525 Rhizomucor pusillus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940080701 chymosin Drugs 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 235000020215 hypoallergenic milk formula Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
- 230000006213 negative regulation of lymphocyte proliferation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99200130 | 1999-01-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200106787B true ZA200106787B (en) | 2002-11-18 |
Family
ID=8239810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200106787A ZA200106787B (en) | 1999-01-19 | 2001-08-16 | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6737076B2 (xx) |
| EP (1) | EP1146794B1 (xx) |
| AR (1) | AR028141A1 (xx) |
| AT (1) | ATE246454T1 (xx) |
| AU (1) | AU781013B2 (xx) |
| BR (1) | BR0007597A (xx) |
| CA (1) | CA2358423C (xx) |
| DE (1) | DE60004325T2 (xx) |
| DK (1) | DK1146794T3 (xx) |
| ES (1) | ES2203435T3 (xx) |
| IL (1) | IL144167A0 (xx) |
| MY (1) | MY129566A (xx) |
| NZ (1) | NZ512866A (xx) |
| TW (1) | TWI251468B (xx) |
| WO (1) | WO2000042863A1 (xx) |
| ZA (1) | ZA200106787B (xx) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999065326A1 (en) | 1998-06-17 | 1999-12-23 | New Zealand Dairy Board | Bioactive whey protein hydrolysate |
| US6551636B2 (en) * | 1999-07-23 | 2003-04-22 | Novozymes A/S | Modification of foaming properties of proteins |
| PL215187B1 (pl) * | 2000-08-21 | 2013-11-29 | Apitope Technology Bristol Ltd | Peptyd tolerogenny, kompozycja farmaceutyczna zawierajaca ten peptyd, peptyd lub kompozycja farmaceutyczna do podawania i zastosowanie peptydu tolerogennego |
| NZ506866A (en) * | 2000-09-11 | 2003-05-30 | New Zealand Dairy Board | Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease |
| BR0114105A (pt) | 2000-09-25 | 2003-07-29 | Nestle Sa | Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas |
| EP1236405B1 (en) * | 2001-03-01 | 2006-06-21 | Societe Des Produits Nestle S.A. | Hypoallergenic formulae inducing oral tolerance to soy proteins |
| JP2003137804A (ja) * | 2001-10-31 | 2003-05-14 | Morinaga Milk Ind Co Ltd | インターロイキン−１８誘導剤 |
| AU2002336717B2 (en) | 2001-11-06 | 2008-04-03 | Novozymes North America, Inc. | Modified whey protein compositions having improved foaming properties |
| TWI317636B (en) * | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
| PL368179A1 (en) * | 2004-05-24 | 2005-11-28 | Sgp & Sons Ab | Proteollytic method for processing proteins and protein hydrolysis products, enriched with exogenous, semi-exogenous and conditionally exogenous amino acids for making therapeutic preparation used in normal and medicinal diets |
| US20060286208A1 (en) * | 2005-06-01 | 2006-12-21 | Nagendra Rangavajla | Methods for producing protein partial hydrolysates and infant formulas containing the same |
| US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| WO2007054587A1 (en) * | 2005-11-14 | 2007-05-18 | Nestec S.A. | Oral tolerance promotion with glycated proteins |
| RU2445992C2 (ru) * | 2006-06-15 | 2012-03-27 | Нестек С.А. | Индукция толерантности к белкам яиц |
| EP1867237A1 (en) | 2006-06-15 | 2007-12-19 | Nestec S.A. | Hypoallergenic Egg |
| CN101795579A (zh) * | 2006-08-04 | 2010-08-04 | Shs国际有限公司 | 无蛋白配方 |
| US20090297545A1 (en) * | 2008-05-27 | 2009-12-03 | Universite Laval | Immunomodulatory dairy peptides and uses thereof |
| EP2258208A1 (en) * | 2009-06-02 | 2010-12-08 | University of Limerick | Protein Product With Modified Antigenicity |
| EP2332428B1 (en) * | 2009-12-04 | 2014-08-20 | MJN U.S. Holdings LLC | Nutritional Formulation comprising a cow's milk peptide-containing hydrolysate and/or peptides derived thereof for tolerance induction |
| WO2011150949A1 (en) | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| EP3097791B1 (en) | 2010-06-04 | 2018-05-16 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| EP2436389A1 (en) * | 2010-10-01 | 2012-04-04 | Nestec S.A. | Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof |
| WO2012077076A1 (en) * | 2010-12-08 | 2012-06-14 | Holt Patrick G | Treating or preventing sensitivity to milk allergens |
| EP2489281A1 (en) * | 2011-02-17 | 2012-08-22 | University of Limerick | A casein hydrolysate |
| WO2013083140A1 (en) | 2011-12-07 | 2013-06-13 | N.V. Nutricia | Beta-lactoglobulin peptides for treating cow's milk protein allergy |
| RU2528068C1 (ru) * | 2013-04-04 | 2014-09-10 | Государственное научное учреждение Всероссийский научно-исследовательский институт молочной промышленности Российской академии сельскохозяйственных наук (ГНУ ВНИМИ Россельхозакадемии) | Способ получения ферментативного сывороточных белков |
| RU2531164C1 (ru) * | 2013-06-11 | 2014-10-20 | Государственное научное учреждение Всероссийский научно-исследовательский институт молочной промышленности Российской академии сельскохозяйственных наук (ГНУ ВНИМИ Россельхозакадемии) | Способ получения низкогидролизованной пептидной композиции из белков молочной сыворотки |
| MY186968A (en) | 2013-12-16 | 2021-08-26 | Nestle Sa | Newly identified peptides for use in the induction of oral tolerance in young mammals |
| BR112016020368A2 (pt) | 2014-03-05 | 2018-01-23 | Ucb Biopharma Sprl | proteínas fc multiméricas |
| WO2016148562A1 (en) * | 2015-03-18 | 2016-09-22 | N.V. Nutricia | Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic |
| GB201509718D0 (en) * | 2015-06-04 | 2015-07-22 | Reacta Biotech Ltd | Oral food challenge meal formulations |
| JP6834989B2 (ja) | 2015-06-12 | 2021-02-24 | コンパニー レティエール ヨーロピエンヌＣｏｍｐａｇｎｉｅ Ｌａｉｔｉｅｒｅ Ｅｕｒｏｐｅｅｎｎｅ | 幼若哺乳動物における経口寛容の誘導及び維持において使用するための寛容原性ペプチドとｔｆｇ−ｂとの組み合わせ |
| US20170020950A1 (en) * | 2015-07-23 | 2017-01-26 | Mead Johnson Nutrition Company | Methods for modulating kinases |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| WO2019212330A1 (en) | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with a specific beta-lactoglobulin peptide |
| WO2019212329A1 (en) | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with specific beta-lactoglobulin peptides |
| EP4054343B1 (en) | 2019-11-07 | 2023-12-27 | N.V. Nutricia | Extensive whey protein hydrolysate with tolerogenic peptides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0321603A1 (fr) * | 1987-12-23 | 1989-06-28 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
| GB9312369D0 (en) * | 1993-06-16 | 1993-07-28 | Sandoz Nutrition Ltd | Organic compounds |
| JPH07138187A (ja) * | 1993-11-16 | 1995-05-30 | Nippon Ham Kk | 経口免疫寛容原、経口慢性関節リウマチ治療剤及び機能性食品 |
| PT827697E (pt) * | 1996-09-06 | 2002-11-29 | Nestle Sa | Inducao da tolerancia ao leite de vaca |
-
1999
- 1999-12-06 MY MYPI99005287A patent/MY129566A/en unknown
-
2000
- 2000-01-12 TW TW089100412A patent/TWI251468B/zh not_active IP Right Cessation
- 2000-01-17 ES ES00912432T patent/ES2203435T3/es not_active Expired - Lifetime
- 2000-01-17 DK DK00912432T patent/DK1146794T3/da active
- 2000-01-17 WO PCT/EP2000/000334 patent/WO2000042863A1/en active IP Right Grant
- 2000-01-17 DE DE60004325T patent/DE60004325T2/de not_active Revoked
- 2000-01-17 IL IL14416700A patent/IL144167A0/xx unknown
- 2000-01-17 NZ NZ512866A patent/NZ512866A/xx unknown
- 2000-01-17 EP EP00912432A patent/EP1146794B1/en not_active Revoked
- 2000-01-17 AT AT00912432T patent/ATE246454T1/de not_active IP Right Cessation
- 2000-01-17 CA CA2358423A patent/CA2358423C/en not_active Expired - Fee Related
- 2000-01-17 AU AU34210/00A patent/AU781013B2/en not_active Ceased
- 2000-01-17 BR BR0007597-3A patent/BR0007597A/pt not_active Application Discontinuation
- 2000-01-19 AR ARP000100245A patent/AR028141A1/es unknown
-
2001
- 2001-07-16 US US09/907,109 patent/US6737076B2/en not_active Expired - Lifetime
- 2001-08-16 ZA ZA200106787A patent/ZA200106787B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1146794B1 (en) | 2003-08-06 |
| EP1146794A1 (en) | 2001-10-24 |
| IL144167A0 (en) | 2002-05-23 |
| NZ512866A (en) | 2002-10-25 |
| AR028141A1 (es) | 2003-04-30 |
| AU3421000A (en) | 2000-08-07 |
| DK1146794T3 (da) | 2003-10-06 |
| US20020037357A1 (en) | 2002-03-28 |
| CA2358423A1 (en) | 2000-07-27 |
| CA2358423C (en) | 2011-07-05 |
| DE60004325D1 (de) | 2003-09-11 |
| WO2000042863A1 (en) | 2000-07-27 |
| DE60004325T2 (de) | 2004-06-09 |
| BR0007597A (pt) | 2001-10-16 |
| AU781013B2 (en) | 2005-04-28 |
| ES2203435T3 (es) | 2004-04-16 |
| TWI251468B (en) | 2006-03-21 |
| ATE246454T1 (de) | 2003-08-15 |
| US6737076B2 (en) | 2004-05-18 |
| MY129566A (en) | 2007-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1146794B1 (en) | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance | |
| Van Beresteijn et al. | Molecular mass distribution immunological properties nutritive value of whey protein hydrolysates | |
| US5780439A (en) | Whey protein hydrolysates and mixtures thereof with casein and/or soy protein hydrolysates | |
| KR101277047B1 (ko) | 저-락토스의 부분적으로 가수분해된 유아용 조제유 | |
| De la Barca et al. | Enzymatic hydrolysis and synthesis of soy protein to improve its amino acid composition and functional properties | |
| EP0629350A1 (en) | Milk protein hydrolysates | |
| AU2013407963B2 (en) | Newly identified peptides for use in the induction of oral tolerance in young mammals | |
| EP1236405B1 (en) | Hypoallergenic formulae inducing oral tolerance to soy proteins | |
| AU2013407963A1 (en) | Newly identified peptides for use in the induction of oral tolerance in young mammals | |
| Boza et al. | Nutritional and Antigenic Characterization of an Enzymic Whey Protein Hydrolyzate | |
| US5951984A (en) | Method for inducing immunological tolerance, immunological tolerance inducing food kit, and immunological tolerance inducer kit | |
| Heyman et al. | Hypersensitivity reaction in an infant fed hydrolyzed lactalbumin contained in a semielemental formula | |
| US5223284A (en) | Products and methods for treating colic | |
| MXPA01007225A (en) | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance | |
| KR20230152127A (ko) | 알레르기성이 감소된 면역원성 단백질 가수분해물 | |
| Wróblewska et al. | Influence of enzymatic cow milk hydrolysates on IgA and IgG response of Balb/c mice organism | |
| JPH0517368A (ja) | 抗アレルギー性母乳強化組成物 | |
| KR20020026640A (ko) | 항원성이 저감된 카제인 가수분해물의 제조방법 및 이가수분해물을 함유하는 유제품 | |
| Khan | Received: 19 th Jan-2013 Revised: 31 st Jan-2013 Accepted: 2 nd Feb-2013 Research article WHEY PROTEIN HYDROLYSATES: TECHNO-FUNCTIONAL PERSPECTIVE | |
| CZ22359U1 (cs) | Hypoalergenní mléčný přípravek pro dospívající a dospělou populaci |